v3.25.2
Share-based Compensation Awards Under Equity Incentive Plan (Details) - Class A common stock
 6 Months Ended
Jun. 30, 2025
$ / shares
shares
Restricted stock  
Restricted Class A Common Stock  
Restricted stock, balance at beginning of the period (in shares) 536,185
Restricted stock, granted in period (in shares) 414,224
Restricted stock, vested in period (in shares) (156,830)
Restricted stock, balance at end of the period (in shares) 793,579
Weighted-average grant date fair value  
Weighted average grant date fair value, restricted stock balance at the beginning of the period (in usd per share) | $ / shares $ 49.14
Weighted average grant date fair value, restricted stock granted (in usd per share) | $ / shares 52.10
Weighted average grant date fair value, restricted stock vested (in usd per share) | $ / shares 41.49
Weighted average grant date fair value, restricted stock balance at the end of the period (in usd per share) | $ / shares $ 52.20
Stock Options  
Options, exercised in period but not converted into shares 0
Employee stock option  
Stock Options  
Options, balance at beginning of the period (in shares) 5,242,236
Options, granted in period (in shares) 1,198,989
Options, exercised in period (in shares) (492,350) [1]
Options, balance at end of the period (in shares) 6,082,058
Options, exercised in period but not converted into shares 364,418
Weighted-average exercise price  
Weighted average exercise price, options balance at beginning of the period (in usd per share) | $ / shares $ 38.23
Weighted average exercise price, options granted in period (in usd per share) | $ / shares 52.05
Weighted average exercise price, exercised in period (in usd per share) | $ / shares 31.18
Weighted average exercise price, options balance at end of the period (in usd per share) | $ / shares $ 40.69
[1] Stock options exercised included 364,418 options that were not converted into shares due to net share settlements to cover the aggregate exercise price and employee withholding taxes.
(b)As a result of the special dividend paid in May 2025, all outstanding stock option awards were adjusted to decrease the exercise price of the options and increase the number of shares issuable under the awards pursuant to an antidilution provision in the Equity Incentive Plan.